Belgium· BE-AMP-SAM170572-00

Spitaderm

A medicinal product containing chlorhexidine digluconate, registered in Belgium by Ecolab.

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSpitadermATC—REGISTER NO.BE-AMP-SAM170572-00PACKS LISTED0CHECKEDSeptember 26, 2026

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Chlorhexidine Digluconate
Manufacturer
Ecolab
Country
Belgium (BE)
ATC code
—
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3c3a715-0939-4e03-9c35-80ebc97321d3
GET /v1/drugs/d3c3a715-0939-4e03-9c35-80ebc97321d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cutaneous solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Spitaderm",
  "name_fr": "Spitaderm",
  "name_nl": "Spitaderm",
  "amp_code": "SAM170572-00",
  "strengths": [
    "5.0000",
    "4.5000",
    "700.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Chlorhexidine Digluconate",
    "Hydrogen Peroxide",
    "2-Propanol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": null,
  "authorisation_numbers": [
    "0910IS0001F011"
  ]
}

See everything about chlorhexidine digluconate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.